Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Northrop Grumman Corp (NOC)

Northrop Grumman Corp (NOC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Northrop Grumman's B-21 Overruns May Finally Surface in Tomorrow's Report, or Later

Barchart Research What to Expect from NOC Earnings NOC Generated April 20, 2026 Current Price $656.98 EPS Estimate $$6.08 Consensus Rating Moderate Buy Average Move 4.53% Northrop Grumman's B-21 Overruns...

NOC : 656.98 (-1.24%)
Northrop Grumman (NOC) To Report Earnings Tomorrow: Here Is What To Expect

Northrop Grumman (NOC) To Report Earnings Tomorrow: Here Is What To Expect

NOC : 656.98 (-1.24%)
Northrop Grumman’s B-21 Raider Powers Unmatched Long-Range Strike Capability

FALLS CHURCH, Va., April 14, 2026 (GLOBE NEWSWIRE) -- Northrop Grumman is accelerating American airpower with the B-21 Raider aircraft, advancing rapidly through its flight test campaign to deliver exceptional...

NOC : 656.98 (-1.24%)
Lockheed Martin Just Scored a $4.7 Billion Army Contract. Does That Make LMT Stock a Buy?

Lockheed Martin has secured a $4.7 billion Army contract. But does that warrant buying LMT shares at current levels? Let’s find out.

LMT : 581.28 (-1.84%)
NOC : 656.98 (-1.24%)
RTX : 195.79 (-0.32%)
Northrop Grumman and U.S. Air Force Accelerate Sentinel Program Momentum

FALLS CHURCH, Va., April 13, 2026 (GLOBE NEWSWIRE) -- Northrop Grumman and the U.S. Air Force are achieving substantial progress across the Sentinel program, advancing toward first flight in 2027 and...

NOC : 656.98 (-1.24%)
The Pentagon Has 268 Days to Replace America’s Most Critical Supply Chain

Oil is surging on the Iran strikes. Gas costs more. Everything costs more. That pain is real.But ...

NOC : 656.98 (-1.24%)
TSLA : 392.50 (-2.03%)
ALOY : 10.90 (-4.13%)
BA : 225.08 (+0.76%)
Raytheon Is a Top Defense Stock to Buy Amid the Iran War, But It Will Also Benefit From a Ceasefire. Here’s How.

The Pentagon is going through Tomahawk cruise missiles at an unprecedented pace.

LMT : 581.28 (-1.84%)
NOC : 656.98 (-1.24%)
$SPX : 7,109.14 (-0.24%)
RTX : 195.79 (-0.32%)
GD : 332.14 (-1.23%)
Chart of the Day: Another 1.5 TLN Reasons to Buy Defense Stocks

Defense stocks have been a no-brainer “buy” given all the geopolitical upheaval of the past few years. Now, investors just got another 1.5 TRILLION reasons to add more.

LMT : 581.28 (-1.84%)
EUAD : 44.02 (-2.18%)
NOC : 656.98 (-1.24%)
ITA : 231.85 (-0.04%)
HII : 392.19 (-0.66%)
BAESY : 122.2500 (-0.81%)
SPY : 708.72 (-0.20%)
US Warns Iran War Could Disrupt Ukraine Weapons Supply Chain, Including Patriot Missiles

U.S. officials have warned allies that ongoing military operations against Iran could delay weapons shipments to Ukraine, as the Pentagon prioritizes munitions for the conflict in the Middle East. The...

NOC : 656.98 (-1.24%)
RTX : 195.79 (-0.32%)
LHX : 348.57 (-0.51%)
What You Need To Know Ahead of Northrop Grumman's Earnings Release

Northrop Grumman is expected to announce its first-quarter results next month, and analysts are projecting a marginal EPS growth.

NOC : 656.98 (-1.24%)
XLI : 173.90 (+0.22%)
$SPX : 7,109.14 (-0.24%)

Barchart Exclusives

Tilray Stock Pops on New Trump-Driven Cannabis Hopes. Should You Chase the Rally?
Tilray shares rally as Trump urges the DOJ to quickly reclassify cannabis as a Schedule III drug. Options pricing suggests TLRY stock could rip higher through mid-September. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.